Industry and charities have created new partnerships with the Government and NHS to scale up rapidly UK diagnostic capacity; supported the NHS to deliver care in a period of exceptional patient demand; and is leading the search for vaccinations and treatments, which will put an end to this epidemic. At the same time, industry has responded to unprecedented demands for the supply of certain medicines and medical products in very challenging conditions.
In addition, the proactive and positive approach to collaboration between companies and bodies in the sector, and with Government, was identified in the Life Science Industrial Strategy and subsequent Sector Deals. This collaborative approach has accelerated and shown results as the UK Life Sciences sector responded to the Covid-19 pandemic.
The Life Sciences Recovery Roadmap sets out policy recommendations that will capitalise on progress made on research, diagnostics, supply and innovation in delivery of healthcare during the covid-19 pandemic. It covers seven key areas:
PAGB’s recommendations on self care, digital healthcare and access to medicines were included in the paper, which is intended to inform the Government’s plans for recovery and set the foundations for building a new partnership between the Life sciences sector, Government and NHS.
Read our media statement.